176 related articles for article (PubMed ID: 32412586)
1. Recent advances in Wilms' tumor predisposition.
Maciaszek JL; Oak N; Nichols KE
Hum Mol Genet; 2020 Oct; 29(R2):R138-R149. PubMed ID: 32412586
[TBL] [Abstract][Full Text] [Related]
2. TRIM28 variants and Wilms' tumour predisposition.
Hol JA; Diets IJ; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MC; Kuiper RP
J Pathol; 2021 Jul; 254(4):494-504. PubMed ID: 33565090
[TBL] [Abstract][Full Text] [Related]
3. Wilms tumor genes.
Huff V; Saunders GF
Biochim Biophys Acta; 1993 Dec; 1155(3):295-306. PubMed ID: 8268188
[TBL] [Abstract][Full Text] [Related]
4. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
[TBL] [Abstract][Full Text] [Related]
5. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
6.
Moore C; Monforte H; Teer JK; Zhang Y; Yoder S; Brohl AS; Reed DR
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32699065
[TBL] [Abstract][Full Text] [Related]
7. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
Hol JA; Kuiper RP; van Dijk F; Waanders E; van Peer SE; Koudijs MJ; Bladergroen R; van Reijmersdal SV; Morgado LM; Bliek J; Lombardi MP; Hopman S; Drost J; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MCJ
J Clin Oncol; 2022 Jun; 40(17):1892-1902. PubMed ID: 35230882
[TBL] [Abstract][Full Text] [Related]
9. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
[TBL] [Abstract][Full Text] [Related]
11. Evidence for genetic heterogeneity in familial Wilms' tumor.
Huff V; Amos CI; Douglass EC; Fisher R; Geiser CF; Krill CE; Li FP; Strong LC; McDonald JM
Cancer Res; 1997 May; 57(10):1859-62. PubMed ID: 9157975
[TBL] [Abstract][Full Text] [Related]
12. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.
Palculict TB; Ruteshouser EC; Fan Y; Wang W; Strong L; Huff V
J Med Genet; 2016 Jun; 53(6):385-8. PubMed ID: 26566882
[TBL] [Abstract][Full Text] [Related]
13. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
[TBL] [Abstract][Full Text] [Related]
14. Wilms tumor genetics.
Huff V
Am J Med Genet; 1998 Oct; 79(4):260-7. PubMed ID: 9781905
[TBL] [Abstract][Full Text] [Related]
15. The pathophysiology of bilateral and multifocal Wilms tumors: What we can learn from the study of predisposition syndromes.
Welter N; Brzezinski J; Treece A; Chintagumpala M; Young MD; Perotti D; Kieran K; Jongmans MCJ; Murphy AJ
Pediatr Blood Cancer; 2023 May; 70 Suppl 2():e29984. PubMed ID: 36094328
[TBL] [Abstract][Full Text] [Related]
16. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel CTR9 germline mutation in a family with Wilms tumor.
Martins AG; Pinto AT; Domingues R; Cavaco BM
Eur J Med Genet; 2018 May; 61(5):294-299. PubMed ID: 29292210
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski CM; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
Nat Commun; 2023 Dec; 14(1):8006. PubMed ID: 38110397
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 7p in Wilms' tumour development.
Powlesland RM; Charles AK; Malik KT; Reynolds PA; Pires S; Boavida M; Brown KW
Br J Cancer; 2000 Jan; 82(2):323-9. PubMed ID: 10646884
[TBL] [Abstract][Full Text] [Related]
20. Role of the WT1 gene in Wilms' tumour.
Haber DA; Housman DE
Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
